이 페이지는 자동 번역되었으며 번역의 정확성을 보장하지 않습니다. 참조하십시오 영문판 원본 텍스트의 경우.

IPV를 경험 한 환자의 경우 평소와 같이 옹호 기반 향상된 치료 (RISE)

2026년 9월 27일 업데이트: Boston University

IPV를 경험하는 환자를 위해 평소와 같이 강점과 권한 부여 (RISE) 대 옹호 기반 향상 치료를 통해 IPV에서 회복

This study aims to improve treatment for Veterans Health Administration (VHA) patients who experience intimate partner violence (IPV). This study will evaluate two brief counseling interventions for VHA patients who have experienced IPV in the past 12 months: Recovering from IPV through Strength and Empowerment (RISE) and advocacy-based Enhanced Care as Usual (ECAU). The RISE intervention includes up to 8 sessions and includes specific topic areas (e.g., social support, health effects, resources). The other intervention, ECAU, includes a single session that includes supportive education about IPV and health effects, discussion of ways to increase safety, and information about resources. This study will test which approach is better for improving self-efficacy and other aspects of health.

Participants will answer surveys about their self-efficacy and other health and safety indicators (e.g., mental health symptoms) right before receiving treatment, approximately 12 weeks later, and then every three months after that for one year. Participation in this research will last about 15 months.

연구 개요

상태

모병

정황

개입 / 치료

연구 유형

중재적

등록 (추정된)

172

단계

  • 해당 없음

연락처 및 위치

이 섹션에서는 연구를 수행하는 사람들의 연락처 정보와 이 연구가 수행되는 장소에 대한 정보를 제공합니다.

연구 연락처

연구 연락처 백업

연구 장소

    • Massachusetts
      • Boston, Massachusetts, 미국, 02130
        • 모병
        • VA Boston Healthcare System
        • 연락하다:
          • Katherine M Iverson, PhD
    • Minnesota
      • Minneapolis, Minnesota, 미국, 55417
        • 모병
        • VA Minneapolis Healthcare System
        • 연락하다:
          • Princess Ackland, PhD
    • Pennsylvania
      • Philadelphia, Pennsylvania, 미국, 19104
        • 모병
        • VA Philadelphia Healthcare System
        • 연락하다:
          • Melissa Dichter, PhD

참여기준

연구원은 적격성 기준이라는 특정 설명에 맞는 사람을 찾습니다. 이러한 기준의 몇 가지 예는 개인의 일반적인 건강 상태 또는 이전 치료입니다.

자격 기준

공부할 수 있는 나이

18년 이상 (성인, 고령자)

건강한 자원 봉사자를 받아들입니다

아니

연구 대상 성별

모두

설명

Inclusion Criteria:

  • patients receiving care at an enrolled site/affiliated Community-Based Outpatient Clinic (CBOC)
  • report experience of past-year physical, psychological, and/or sexual IPV on an established screening tool used to detect IPV in VHA, and
  • be able to provide informed consent including permission to have intervention sessions recorded

Exclusion Criteria:

  • severe cognitive impairment,
  • suicide or homicide intent with a specific plan
  • untreated or unstable symptoms of mania or psychosis

공부 계획

이 섹션에서는 연구 설계 방법과 연구가 측정하는 내용을 포함하여 연구 계획에 대한 세부 정보를 제공합니다.

연구는 어떻게 설계됩니까?

디자인 세부사항

  • 주 목적: 치료
  • 할당: 무작위
  • 중재 모델: 병렬 할당
  • 마스킹: 없음(오픈 라벨)

무기와 개입

참가자 그룹 / 팔
개입 / 치료
실험적: RISE (Recovering from Intimate Partner Violence through Strengths and Empowerment)

Participants randomized to the RISE arm will have 1 or more RISE sessions.

RISE is personalized, trauma-informed, empowerment-oriented and variable-length, consisting of an initial 60-minute session and up to 7 additional 45-minute sessions (1-8 sessions total).

활성 비교기: Advocacy-based ECAU (Enhanced Care as Usual)

Participants randomized to this arm will have a single Advocacy-based ECAU session

Advocacy-based ECAU is a single 60-minute trauma-informed counseling intervention that includes supportive education, validating and empathetic statements, safety planning, resource provision and referrals.

연구는 무엇을 측정합니까?

주요 결과 측정

결과 측정
측정값 설명
기간
Self-efficacy
기간: Baseline, 3 months, 6 months. 9 months, 12 months, 15 months

Self-efficacy will be assessed with the General Self-Efficacy Scale (GSES), a 10-item instrument with possible responses for each item from 1 to 4 where 1= Not at all true, 2= Hardly true, 3= Moderately true, and 4=Exactly true.Scores can range from 10 to 40 and higher scores indicate more self efficacy.

Baseline, 3 months, 6 months. 9 months, 12 months, 15 months

2차 결과 측정

결과 측정
측정값 설명
기간
Depressive symptoms
기간: Baseline, 3 months, 6 months. 9 months, 12 months, 15 months

Depressive symptoms will be assessed with the Center for Epidemiologic Studies Depression Scale (CESD), a 20-item instrument with possible responses for each item from 0 to 3 where 0= Rarely or none of the time (less than 1 day), 1= Some or a little of the time (1-2 days), 2= Occasionally or a moderate amount of the time (3-4 days), and 3= Most or all of the time (5-7 days). Possible range of scores is 0 to 60, with the higher scores indicating more depressive symptoms.

Baseline, 3 months, 6 months. 9 months, 12 months, 15 months
Post traumatic stress disorder (PTSD) symptoms
기간: Baseline, 3 months, 6 months. 9 months, 12 months, 15 months

PTSD symptoms will be assessed with the PTSD Checklist -DSM-5, a 20-item self-report measure of the DSM-5 symptoms of PTSD. A 5-point Likert scale is used for each item from 0 = "Not at all" to 4 = "Extremely". Total possible scores can range from 0 to 80 with higher scores indicating more PTSD symptoms.

Baseline, 3 months, 6 months. 9 months, 12 months, 15 months
Alcohol use
기간: Baseline, 3 months, 6 months. 9 months, 12 months, 15 months

Alcohol use will be assessed with the Alcohol Use Disorders Identification Test-10 (AUDIT-10), a 10-item instrument with possible responses for each item from 0 to 4 for questions 1-8 and possible responses of 0, 2, and 4 for questions 9 and 10. Total possible scores can range from 0 to 40 with higher scores indicating greater alcohol use.

Baseline, 3 months, 6 months. 9 months, 12 months, 15 months
Hopelessness
기간: Baseline, 3 months, 6 months. 9 months, 12 months, 15 months

Hopelessness will be assessed by the 20-item Beck Hopelessness Scale (BHS). The BHS is scored by adding up the responses to 20 true-false questions. The possible score range is 0-20, with higher scores indicating greater hopelessness.

Baseline, 3 months, 6 months. 9 months, 12 months, 15 months
Self-reported quality of life
기간: Baseline, 3 months, 6 months. 9 months, 12 months, 15 months

Quality of life will be assessed by World Health Organization - Quality of Life, Brief WHOQOL-BREF instrument, a 26-item instrument consisting of four domains: physical health (7 items), psychological health (6 items), social relationships (3 items), and environmental health (8 items); it also contains QOL and general health items. Each individual item of the WHOQOL-BREF is scored from 1 to 5 on a response scale, which is stipulated as a five-point ordinal scale. The scores are then transformed linearly to a 0-100-scale with higher scores indicating a better quality of life.

Baseline, 3 months, 6 months. 9 months, 12 months, 15 months
Valued living
기간: Baseline, 3 months, 6 months. 9 months, 12 months, 15 months

Valued living will be assessed with the Valued Living Questionnaire (VLQ) focusing on 10 valued domains of living which include (1) family, (2) marriage/couples, intimate relations, (3) parenting, (4) friendship, (5) work, (6) education, (7) recreation, (8) spirituality, (9) citizenship, and (10) physical self-care. Each domain is rated on a scale of 1-10, based on the level of importance to the respondent and the extent to which they have lived consistent with their values in the past week. A total score is calculated by multiplying the importance and consistency ratings for each domain, and then averaging those scores. Total scores range from 10 to 100 with higher scores indicating greater alignment with one's values.

Baseline, 3 months, 6 months. 9 months, 12 months, 15 months
IPV
기간: Baseline, 3 months, 6 months. 9 months, 12 months, 15 months

Experiences of IPV from past or a current intimate partner will be measured using subscales of the Revised Conflict Tactics Scale (CTS-2). The physical aggression (12 items), psychological aggression (8 items), and sexual coercion (7 items) subscales include 27 items regarding the frequency of different IPV experiences (0=this has never happened, 1=1 time, 2=2 times, 3=3-5 times, 4=6-10 times, 5=11-20 times, and 6=20+ times). Items are summed for a total frequency score. Additionally, the number of different IPV behaviors experienced can be tallied to reflect a indicate the number of different IPV behaviors experienced. Higher scores reflect greater levels of IPV experience.

Baseline, 3 months, 6 months. 9 months, 12 months, 15 months
Measure of Victim Empowerment Related to Safety
기간: Baseline, 3 months, 6 months. 9 months, 12 months, 15 months

Safety-related Empowerment will be measured with the Measure of Victim Empowerment Related to Safety (MOVERS), a 13- item measure that consists of three subscales: internal resources (6 items), expectations of support (4 items), and trade-offs (3 items), with response options on a scale from 1-5, with 1 being "never true" and 5 being "always true" for each internal resource and expectation of support subscale question. Responses options for the trade-off subscale are reverse scored with 1 = Always true and 5= Never true. Total possible scores can range from 13 to 65, with higher scores indicating higher levels of empowerment.

Baseline, 3 months, 6 months. 9 months, 12 months, 15 months
Health care and social service use
기간: Baseline, 3 months, 6 months. 9 months, 12 months, 15 months

Items adapted from the National Survey of Veterans and prior studies examining health and social service use among individuals experiencing IPV, particularly in terms of VA and non-VHA psychosocial health services (e.g., mental health, housing, domestic violence agencies). The number and types of psychosocial treatment services will be examined.

Baseline, 3 months, 6 months. 9 months, 12 months, 15 months
VHA health care use
기간: 12 months before baseline, 12 months after baseline

VHA health care use will be extracted from the electronic medical records. The types and number of services used, particularly psychosocial health services, will be examined.

12 months before baseline, 12 months after baseline
Treatment satisfaction
기간: 3 months

Treatment satisfaction will be assessed using the 8-item Client Satisfaction Questionnaire-8 (CSQ-8). Possible scores range from 8 to 32, with higher values indicating higher treatment satisfaction.

3 months
Perceived Benefits/Harms
기간: 3 months

Perceived benefits/harms from participating in the interventions will be measured using 6 items adapted from prior studies. Possible responses on a Likert scale range from 1= strongly disagree to 5 = strongly agree, with item 4 reverse scored. Individual item scores and total scores will be examined.

3 months

공동 작업자 및 조사자

여기에서 이 연구와 관련된 사람과 조직을 찾을 수 있습니다.

스폰서

협력자

수사관

  • 수석 연구원: Katherine M Iverson, PhD, V Boston Healthcare System, BU CASchool Medicine Psychiatry
  • 수석 연구원: Melissa Dichter, PhD MSW, VA Philadelphia Healthcare System

연구 기록 날짜

이 날짜는 ClinicalTrials.gov에 대한 연구 기록 및 요약 결과 제출의 진행 상황을 추적합니다. 연구 기록 및 보고된 결과는 공개 웹사이트에 게시되기 전에 특정 품질 관리 기준을 충족하는지 확인하기 위해 국립 의학 도서관(NLM)에서 검토합니다.

연구 주요 날짜

연구 시작 (실제)

2025년 9월 15일

기본 완료 (추정된)

2030년 1월 1일

연구 완료 (추정된)

2030년 1월 1일

연구 등록 날짜

최초 제출

2025년 4월 1일

QC 기준을 충족하는 최초 제출

2025년 4월 1일

처음 게시됨 (실제)

2025년 4월 2일

연구 기록 업데이트

마지막 업데이트 게시됨 (실제)

2026년 9월 30일

QC 기준을 충족하는 마지막 업데이트 제출

2026년 9월 27일

마지막으로 확인됨

2026년 9월 1일

추가 정보

이 연구와 관련된 용어

기타 연구 ID 번호

  • H-45215
  • BPS-2023C2-33320 (기타 보조금/기금 번호: PCORI)

개별 참가자 데이터(IPD) 계획

개별 참가자 데이터(IPD)를 공유할 계획입니까?

아니요

약물 및 장치 정보, 연구 문서

미국 FDA 규제 의약품 연구

아니

미국 FDA 규제 기기 제품 연구

아니

이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .